Elsiglutide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameElsiglutide
Drug Alias NameZP-1846
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsDiarrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUkraine +[9] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelsinn Healthcare Sa
Active IndicationsN/A
Inactive IndicationsDiarrhea

Other Information

ATC CodeN/A
Related LinksN/A